Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.
Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page
- CheckyesterdayChange DetectedLocations section updated with a revised list of study sites, including additions and removals across the United States and international regions.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2.SummaryDifference0.5%
- Check37 days agoChange DetectedStandardized the Taiwan site name by replacing 'Tainan City, Taiwan' with 'Tainan, Taiwan' in the locations section.SummaryDifference0.3%
- Check51 days agoChange DetectedMinor UI updates and timestamp changes observed; core study details remain unchanged, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check80 days agoChange DetectedAdded a government funding notice and a v3.2.0 revision tag; removed the previous v3.1.0 tag. If any time-sensitive content (operating status) is now present, it should be considered updated.SummaryDifference3%
- Check87 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%
Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.